Synthesis and biological evaluation of novel coumarin-based inhibitors of Cdc25 phosphatases

被引:39
作者
Valente, Sergio [1 ]
Bana, Emilie [1 ]
Viry, Elodie [1 ]
Bagrel, Denyse [1 ]
Kirsch, Gilbert [1 ]
机构
[1] Univ Paul Verlaine, Lab Ingenierie Mol & Biochim Pharmacol, Inst Jean Barriol, FR CNRS 2843, F-57070 Metz, France
关键词
Cdc25; phosphatases; Coumarins; Chalcones; Heck coupling; CELL-GROWTH; SPECIFICITY;
D O I
10.1016/j.bmcl.2010.07.130
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The cell division cycle 25 (Cdc25) family of proteins are dual specificity phosphatases that activate cyclin-dependent kinase (CDK) complexes, which in turn regulate progression through the cell division cycle. Overexpression of Cdc25 proteins has been reported in a wide variety of cancers; their inhibition may thus represent a novel approach for the development of anticancer therapeutics. Herein we report new coumarin-based scaffolds endowed with a selective inhibition against Cdc25A and Cdc25C, being 6a and 6d the most efficient inhibitors and worthy of further investigation as anticancer agents. (C) 2010 Elsevier Ltd. All rights reserved.
引用
收藏
页码:5827 / 5830
页数:4
相关论文
共 29 条
[1]   Cell Cycle Control by the CDC25 Phosphatases [J].
Aressy, Bernadette ;
Ducommun, Bernard .
ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2008, 8 (08) :818-824
[2]   Structures of human monoamine oxidase B complexes with selective noncovalent inhibitors: Safinamide and coumarin analogs [J].
Binda, Claudia ;
Wang, Jin ;
Pisani, Leonardo ;
Caccia, Carla ;
Carotti, Angelo ;
Salvati, Patricia ;
Edmondson, Dale E. ;
Mattevi, Andrea .
JOURNAL OF MEDICINAL CHEMISTRY, 2007, 50 (23) :5848-5852
[3]   The when and wheres of CDC25 phosphatases [J].
Boutros, R ;
Dozier, C ;
Ducommun, B .
CURRENT OPINION IN CELL BIOLOGY, 2006, 18 (02) :185-191
[4]   CDC25 phosphatases in cancer cells: key players? Good targets? [J].
Boutros, Rose ;
Lobjois, Valerie ;
Ducommun, Bernard .
NATURE REVIEWS CANCER, 2007, 7 (07) :495-507
[5]   Activity of novel Cdc25 inhibitors and preliminary evaluation of their potentiation of chemotherapeutic drugs in human breast cancer cells [J].
Brault, Laurent ;
Bagrel, Denyse .
LIFE SCIENCES, 2008, 82 (5-6) :315-323
[6]   Synthesis and biological evaluation of dialkylsubstituted maleic anhydrides as novel inhibitors of Cdc25 dual specificity phosphatases [J].
Brault, Laurent ;
Denance, Mickael ;
Banaszak, Estelle ;
El Maadidi, Souhayla ;
Battaglia, Eric ;
Bagrel, Denyse ;
Samadi, Mohammad .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2007, 42 (02) :243-247
[7]   IRC-083864, a novel his quinone inhibitor of CDC25 phosphatases active against human cancer cells [J].
Brezak, Marie-Christine ;
Valette, Annie ;
Quaranta, Muriel ;
Contour-Galcera, Marie-Odile ;
Jullien, Denis ;
Lavergne, Olivier ;
Frongia, Celine ;
Bigg, Dennis ;
Kasprzyk, Philip G. ;
Prevost, Gregoire Pierre ;
Ducommun, Bernard .
INTERNATIONAL JOURNAL OF CANCER, 2009, 124 (06) :1449-1456
[8]   Inhibition of human tumor cell growth in vivo by an orally bioavailable inhibitor of CDC25 phosphatases [J].
Brezak, MC ;
Quaranta, M ;
Contour-Galcera, MO ;
Lavergne, O ;
Mondesert, O ;
Auvray, P ;
Kasprzyk, PG ;
Prevost, GP ;
Ducommun, B .
MOLECULAR CANCER THERAPEUTICS, 2005, 4 (09) :1378-1387
[9]   Novel synthetic inhibitor of CDC25 phosphatases:: BN82002 [J].
Brezak, MC ;
Quaranta, M ;
Mondésert, O ;
Galcera, MO ;
Lavergne, O ;
Alby, F ;
Cazales, M ;
Baldin, W ;
Thurieau, C ;
Harnett, J ;
Lanco, C ;
Kasprzyk, PG ;
Prevost, GP ;
Ducommun, B .
CANCER RESEARCH, 2004, 64 (09) :3320-3325
[10]   FLAVONOIDS .2. REARRANGEMENT OF 2,2-DIMETHYL-DELTA3-ISOFLAVENES TO INDENES [J].
COOK, CE ;
CORLEY, RC ;
WALL, ME .
JOURNAL OF ORGANIC CHEMISTRY, 1965, 30 (12) :4120-&